International Clinical Trial: Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department: A Randomized Non-inferiority Trial

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816302) titled 'Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department: A Randomized Non-inferiority Trial' on Sept. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Tehran University of Medical Sciences

Condition: Pain Ketorolac Intranasal Drug Administration

Intervention: Drug: 20mg intranasal ketorolac

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: O...